UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trastuzumab for the Treatment of Salivary Duct Carcinoma

The oncologist (Dayton, Ohio), 2013-03, Vol.18 (3), p.294-300

2013

Volltextzugriff (PDF)

Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy

Journal of Immunotherapy and Precision Oncology, 2024-08, Vol.7 (3), p.171-177

2024

Volltextzugriff (PDF)

Carcinoma of unknown primary: Molecular tumor board‐based therapy

CA: a cancer journal for clinicians, 2022-11, Vol.72 (6), p.510-523

2022

Volltextzugriff (PDF)

Genomic profiling and precision medicine in complex ameloblastoma

Head & neck, 2023-04, Vol.45 (4), p.816-826

2023

Volltextzugriff (PDF)

A rare case of insulinoma presenting with postprandial hypoglycemia

The American journal of case reports, 2014-11, Vol.15, p.488-491

2014

Volltextzugriff (PDF)

Severe enterocolitis with capecitabine (CAPE) is not a predictor of gastrointestinal (GI) toxicity with infusional 5-fluorouracil (5-FU)–based regimens: An institutional analysis

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.89-89

2023

Volltextzugriff (PDF)

Impact of statin type and intensity on cisplatin-related hearing loss

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.192-192

2022

Volltextzugriff (PDF)

Initial findings from the DREAM-GI national database: Assessing the efficacy and safety of neoadjuvant immunotherapy (NIT) in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) gastrointestinal (GI) cancer

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.736-736

2024

Volltextzugriff (PDF)

Prognostic effect of RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.191-191

2022

Volltextzugriff (PDF)

The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.105-105

2023

Volltextzugriff (PDF)

Smartphone pain app for assessment of radiation-induced oral mucositis pain

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.420-420

2022

Volltextzugriff (PDF)

Preliminary antitumor activity of COM701 in combination with COM902 and pembrolizumab in patients with MSS-CRC and liver metastases

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3597-3597

2024

Volltextzugriff (PDF)

Clinical course and outcome of patients developing capecitabine-induced non-neutropenic enterocolitis (NNEC): An institutional analysis

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.656-656

2022

Volltextzugriff (PDF)

Definitive chemoradiation for oligometastatic esophageal cancer patients

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.359-359

2022

Volltextzugriff (PDF)

Pan-cancer analysis of tumor mutation burden and other key ICI biomarkers in the Indian cohort

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18872-e18872

2023

Volltextzugriff (PDF)

ATM or CHEK2 alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.754-754

2023

Volltextzugriff (PDF)

On the right TRACK: Providing comprehensive genomic profiling (CGP) and molecular tumor board (MTB) for patients (pts) with rare cancers

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3127-3127

2024

Volltextzugriff (PDF)

Definitive chemoradiotherapy +/- induction chemotherapy in esophageal cancer: A real-world experience

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16072-e16072

2022

Volltextzugriff (PDF)

Survival outcome and treatment response of patients with young-onset locally advanced rectal cancer (YO-LARC) receiving total neoadjuvant therapy (TNT)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.44-44

2022

Volltextzugriff (PDF)

Targeted therapy (TT) in patients with KRAS wildtype (WT) pancreatic ductal adenocarcinoma (PDAC) produces durable response

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.596-596

2022

Volltextzugriff (PDF)

MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS -mutated advanced pancreatic ductal adenocarcinoma (PDAC)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16260-e16260

2022

Volltextzugriff (PDF)

Comprehensive genomic profiling (CGP) of fibrolamellar oncocytic hepatoma (FLO) and conventional hepatocellular carcinomas (HCC): An observational study

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.474-474

2022

Volltextzugriff (PDF)

Reducing refeeding syndrome incidence among patients with head and neck cancer: A quality improvement initiative

JCO oncology practice, 2023-11, Vol.19 (11_suppl), p.459-459

2023

Volltextzugriff (PDF)

Racial Disparities in Palliative and Hospice Care Beliefs of Lung Cancer Patients

Shreenivas, Aditya V

2018

Volltextzugriff (PDF)

Retrospective review of patients treated with intensity modulated radiation therapy (IMRT) with or without concurrent chemotherapy for locally advanced thyroid cancer: The Dana-Farber experience

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e16060-e16060

2012

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)
Dissertationen
(1)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

6 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Trastuzumab for the Treatment of Salivary Duct Carcinoma

Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and Immunotherapy

Carcinoma of unknown primary: Molecular tumor board‐based therapy

Genomic profiling and precision medicine in complex ameloblastoma

A rare case of insulinoma presenting with postprandial hypoglycemia

Severe enterocolitis with capecitabine (CAPE) is not a predictor of gastrointestinal (GI) toxicity with infusional 5-fluorouracil (5-FU)–based regimens: An institutional analysis

Impact of statin type and intensity on cisplatin-related hearing loss

Initial findings from the DREAM-GI national database: Assessing the efficacy and safety of neoadjuvant immunotherapy (NIT) in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) gastrointestinal (GI) cancer

Prognostic effect of RAS/BRAF mutations in patients (pts) with metastatic colorectal cancer (mCRC)

The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world

Smartphone pain app for assessment of radiation-induced oral mucositis pain

Preliminary antitumor activity of COM701 in combination with COM902 and pembrolizumab in patients with MSS-CRC and liver metastases

Clinical course and outcome of patients developing capecitabine-induced non-neutropenic enterocolitis (NNEC): An institutional analysis

Definitive chemoradiation for oligometastatic esophageal cancer patients

Pan-cancer analysis of tumor mutation burden and other key ICI biomarkers in the Indian cohort

ATM or CHEK2 alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma

On the right TRACK: Providing comprehensive genomic profiling (CGP) and molecular tumor board (MTB) for patients (pts) with rare cancers

Definitive chemoradiotherapy +/- induction chemotherapy in esophageal cancer: A real-world experience

Survival outcome and treatment response of patients with young-onset locally advanced rectal cancer (YO-LARC) receiving total neoadjuvant therapy (TNT)

Targeted therapy (TT) in patients with KRAS wildtype (WT) pancreatic ductal adenocarcinoma (PDAC) produces durable response

MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS -mutated advanced pancreatic ductal adenocarcinoma (PDAC)

Comprehensive genomic profiling (CGP) of fibrolamellar oncocytic hepatoma (FLO) and conventional hepatocellular carcinomas (HCC): An observational study

Reducing refeeding syndrome incidence among patients with head and neck cancer: A quality improvement initiative

Racial Disparities in Palliative and Hospice Care Beliefs of Lung Cancer Patients

Retrospective review of patients treated with intensity modulated radiation therapy (IMRT) with or without concurrent chemotherapy for locally advanced thyroid cancer: The Dana-Farber experience

Suchergebnisse filtern